CYLTEZO vs NEXCEDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. CYLTEZO and NEXCEDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	CYLTEZO	NEXCEDE
Rating	72/100	70/100
Pharmacy pays	—	~$193.86 /30
Type	RX	RX
Active ingredient	ADALIMUMAB-ADBM	KETOPROFEN
Manufacturer	Boehringer Ingelheim	Novartis
Dosage forms	Kit	Film
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis	Rheumatoid Arthritis, Dysmenorrhea, Osteoarthritis

cyltezo nexcede

Rating

72/100

70/100

Pharmacy pays

—

~$193.86 /30

Type

Active ingredient

ADALIMUMAB-ADBM

KETOPROFEN

Manufacturer

Boehringer Ingelheim

Novartis

Dosage forms

Kit

Film

Drug class

—

Boxed warning

None

Treats

Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

Rheumatoid Arthritis, Dysmenorrhea, Osteoarthritis

Frequently asked questions

Which is better-rated, Cyltezo or Nexcede?

By our independent rating, Cyltezo scores higher — 3.6 vs 3.5 out of 5 for Nexcede. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Cyltezo and Nexcede?

Cyltezo contains Adalimumab-Adbm, while Nexcede contains Ketoprofen — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.